Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Exome Sequencing Identifies Mecom Missense Variant As Prognostic Marker for Overall Survival of Elderly Acute Myeloid Patients Treated with Azacitidine

Pierre Bories, MD, Naïs Prade, Bastien Cabarrou, Stéphanie Lagarde, Julien Plenecassagnes, Isabelle Luquet, MD, Veronique De Mas, Thomas Filleron, PhD, Manon Cassou, Audrey Sarry, Luc Matthieu Fornecker, Célestine Simand, MD, Sarah Bertoli, MD PhD, Hinrich Gronemeyer, Christian Recher, MD PhD, Eric Delabesse, MD PhD

Blood (2018) 132 (Supplement 1): 1467.

https://doi.org/10.1182/blood-2018-99-117336

Published: 2018

Journal Articles

TP53 Mutations Negatively Impact Survival of Acute Myeloid Leukemia Patients Treated with Standard Doses of Azacitidine

Pierre Bories, MD, Naïs Prade, Stéphanie Lagarde, Bastien Cabarrou, Julien Plenecassagnes, Isabelle Luquet, MD, Veronique De Mas, Thomas Filleron, PhD, Manon Cassou, Audrey Sarry, Luc Matthieu Fornecker, Célestine Simand, MD, Sarah Bertoli, MD PhD, Hinrich Gronemeyer, Christian Recher, MD PhD, Eric Delabesse, MD PhD

Blood (2018) 132 (Supplement 1): 2745.

https://doi.org/10.1182/blood-2018-99-117219

Published: 2018

Journal Articles

Leukemic transformation by the APL fusion protein PRKAR1A-RARα critically depends on recruitment of RXRα

Jihui J. Qiu, Xiaoxi Lu, Bernd B. Zeisig, Zhigui Ma, Xun Cai, Saijuan Chen, Hinrich Gronemeyer, David J. Tweardy, Chi Wai Eric So, Shuo Dong

Blood (2010) 115 (3): 643–652.

https://doi.org/10.1182/blood-2009-07-232652

Published: 2010

Includes: Supplemental data

Journal Articles

Recruitment of RXRα by Homo-Oligomeric RARα Is a Key for RARα-Mediated Transformation.

Bernd B. Zeisig, PhD, Colin Kwok, PhD, Amanda J. Wilson, BSc, Arthur Zelent, PhD, Hinrich Gronemeyer, PhD, Shuo Dong, MD PhD, Chi Wai Eric So, PhD

Blood (2006) 108 (11): 360.

https://doi.org/10.1182/blood.V108.11.360.360

Published: 2006

Journal Articles

Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of AML by Protein Kinase A-Mediated De-Subordination.

Ettore Mariano Schiavone, MD, Lucia Altucci, MD, Mariacarla De Simone, MD, Felicetto Ferrara, MD, Aurélie Rossin, Fellow, Oliver Hirsch, Fellow, Angela Nebbioso, Fellow, Dominique Vitoux, MD, Emmanuelle Wilhelm, Fellow, Fabien Guidez, PhD, Arthur Zelent, MD, David Grimwade, MD, Hugues de Thé, MD, Hinrich Gronemeyer, PhD

Blood (2006) 108 (11): 2235.

https://doi.org/10.1182/blood.V108.11.2235.2235

Published: 2006

NARROW

Exome Sequencing Identifies Mecom Missense Variant As Prognostic Marker for Overall Survival of Elderly Acute Myeloid Patients Treated with Azacitidine

TP53 Mutations Negatively Impact Survival of Acute Myeloid Leukemia Patients Treated with Standard Doses of Azacitidine

Leukemic transformation by the APL fusion protein PRKAR1A-RARα critically depends on recruitment of RXRα

Recruitment of RXRα by Homo-Oligomeric RARα Is a Key for RARα-Mediated Transformation.

Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of AML by Protein Kinase A-Mediated De-Subordination.

Email alerts

ASH Publications

American Society of Hematology

Exome Sequencing Identifies Mecom Missense Variant As Prognostic Marker for Overall Survival of Elderly Acute Myeloid Patients Treated with Azacitidine

TP53 Mutations Negatively Impact Survival of Acute Myeloid Leukemia Patients Treated with Standard Doses of Azacitidine

Leukemic transformation by the APL fusion protein PRKAR1A-RARα critically depends on recruitment of RXRα

Recruitment of RXRα by Homo-Oligomeric RARα Is a Key for RARα-Mediated Transformation.

Rexinoid-Triggered Differentiation and Tumor-Selective Apoptosis of AML by Protein Kinase A-Mediated De-Subordination.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only